HUMAN MICROBIOME MARKET ANALYSIS

Human Microbiome Market, By Product Type [Food (Probiotics, Prebiotics, Medical Food Supplements, Others (Symbiotic, Antibiotics, etc.)), Microbome Drugs, Fecal Microbiota Transplant], By Application [Therapeutics, Diagnostics, Nutrition and Deities, Others (Cosmetics, Animal health etc.)], By Disease Indication (Auto Immune Disorder, Clostridium Difficile Infection, Metabolic Disorder, Inflammatory Bowel disorder, Infectious Diseases, and Others (Cancer, Rare Diseases), By Distribution Channel (Hospital, Retail Pharmacies, and Online Pharmacies), and By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023
Code : CMI182
Pages :180
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Global Human Microbiome Market - Key Players

Major players operating in the global human microbiome market include Seres Therapeutics, Biomesense, Microbiotica, Infant Bacterial Therapeutics AB, Vedanta Biosciences, Inc., SECOND GENOME THERAPEUTICS, 4D Pharma Ferring Inc, Enterome, BiomX, MaaT Pharma, Azitra, Illumina, Inc, Locus Biosciences, Inc, Finch Therapeutics Group, Inc, Rebiotix Inc, Servatus Ltd, Microbiome Research Pvt. Ltd, AOBiome, Axial Therapeutics, Inc, Biomica.

Human Microbiome Market Report Snapshots